Emcure Pharmaceuticals Limited (EMCURE) Financial Statements

2 Followers

Emcure Pharmaceuticals Limited Financial Overview

Emcure Pharmaceuticals Limited's market cap is currently ₹328.46B. The company's EPS TTM is ₹22.886; its P/E ratio is 32.72; and it has a dividend yield of 0.21%. Emcure Pharmaceuticals Limited is scheduled to report earnings on May 5, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 25	Mar 25
Income Statement
Total Revenue	₹ 78.08B	₹ 92.04B
Gross Profit	₹ 275.05M	₹ 35.79B
Operating Income	₹ 10.85B	₹ 13.74B
EBITDA	₹ 14.95B	₹ 13.74B
Net Income	₹ 6.81B	₹ 9.24B
Balance Sheet
Cash & Short-Term Investments	₹ 1.98B	₹ 1.48B
Total Assets	₹ 82.33B	₹ 96.12B
Total Debt	₹ 10.23B	₹ 15.21B
Net Debt	₹ 9.01B	₹ 13.74B
Total Liabilities	₹ 35.91B	₹ 46.36B
Stockholders' Equity	₹ 44.46B	₹ 49.50B
Cash Flow
Free Cash Flow	₹ 4.45B	₹ 4.90B
Operating Cash Flow	₹ 8.52B	₹ 8.51B
Investing Cash Flow	₹ -940.01M	₹ -11.95B
Financing Cash Flow	₹ -8.14B	₹ 4.38B

Currency in INR

Emcure Pharmaceuticals Limited Earnings and Revenue History

Income Statement >

Emcure Pharmaceuticals Limited Debt to Assets

Balance Sheet >

Emcure Pharmaceuticals Limited Cash Flow

Cash Flow >

Emcure Pharmaceuticals Limited Forecast EPS vs Actual EPS

Earnings >